Syneos Health Promotes Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs


MORRISVILLE, NC, April 19, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the promotions of two senior internal executives – Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Vice President. Executive, Medical Affairs.

“Elevating Baba and Suma into these new strategic roles demonstrates our commitment to advancing integrated solutions for customers and top talent within the organization,” said Alistair Macdonald, CEO of Syneos Health. “Both Baba and Suma bring deep product development experience and leadership skills to take our technology, data and medical affairs capabilities to the next level. We are thrilled to celebrate their career advancement.

Baba Shetty

As President, Technology and Data Solutions, Baba Shetty will be a member of the leadership team, responsible for developing customer-facing technologies, including AI-based tools and advanced data solutions, to solve business challenges. critical business. Baba led the Syneos Health team that developed Kinetic™, a modern engagement capability comprising applied data science, experience strategy and performance analytics for use in patient recruitment for clinical trials , marketing support and advanced data management. In his new role, he will continue to oversee this solution, which is part of the company’s dynamic assembly.® network, an open ecosystem of cutting-edge data and technology solutions that includes in-house capabilities and curated vendor relationships designed to strategically address the nuances of unique customer engagements.

Baba brings deep technology-focused expertise and will be responsible for delivering new advancements to Syneos Health’s digital innovation and analytics platforms. He will be instrumental in integrating RxDataScience, a recently acquired data engineering, data management and artificial intelligence company, and StudyKIK, a leading clinical trial recruitment and retention company based on the technology, in dynamic assembly® network. He will also oversee the company’s relationship and investment in Exeevo, and lead the integration of new and existing digital and technology partnerships to drive business transformation. The new Technology and Data Solutions organization will be part of the Clinical Solutions reportable segment.

Macdonald added, “Baba’s deep expertise and strong track record of success in delivering technology, digital and data-driven solutions across the product development lifecycle is unparalleled. I am delighted that he leads and develops our technological solutions. »

Suma Ramadas

As Executive Vice President, Medical Affairs, Suma Ramadas will lead the creation and delivery of a comprehensive Medical Affairs solution that seamlessly connects the organization’s high-value capabilities across the lifecycle. of the product, from development to commercialization.

Suma will work collaboratively with medical affairs leaders across the company to develop a full-service, best-in-class medical affairs business. She will also continue to lead the Medical Affairs Consulting Organization. As a founding member of Syneos Health Women’s Group, Suma plays an active role in advancing women’s careers by providing workplace presence and enabling personal and professional growth.

“Suma’s new role is designed to leverage the significant growth opportunity in medical business, unifying our existing talent and expertise to continue to deliver our comprehensive set of solutions,” said Michelle Keefe, President, Business medical and commercial solutions, Syneos Health. “His outstanding leadership will be instrumental in the continued growth of this high-value market.”

About Syneos Health
Syneos Health® (Nasdaq: SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically combining clinical development, medical affairs and commercial capabilities to meet modern market realities.

We unite approximately 28,000 minds, in more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together, we share our knowledge, use the latest technologies and apply advanced business practices to accelerate our customers’ delivery of important therapies to patients.

Syneos Health supports a diverse, equitable and inclusive culture that cares about colleagues, customers, patients, communities and the environment.

Learn more about how we’re shortening the distance between the lab and life®to visit or subscribe to our podcast.


About Author

Comments are closed.